BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Pharmacogenetics
,
Ciprofibrate
,
rs2230926
,
FABP1
,
T cell receptor signaling pathway
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
chek2 protein, human
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
T-cell lymphoma CUTLL1 cells with SF3B1 shRNA knockdown
T-cell lymphoma CUTLL1 cells treated with splicing inhibitor E7107
Explore Curated Studies Results
Literature
Most Relevant Literature
ENIGMA CHEK2gether Project: A Comprehensive Study Identifies Functionally Impaired CHEK2 Germline Mi…
Inherited CHEK2 p.H371Y mutation in solitary rectal ulcer syndrome among familial patients: A case r…
ASO Author Reflections: Contralateral Prophylactic Mastectomy in Breast Cancer Patients with CHEK2 G…
A founder CHEK2 pathogenic variant in association with kidney cancer.
Somatic loss of the remaining allele occurs approximately in half of CHEK2-driven breast cancers and…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Olaparib In Metastatic Breast Cancer
M6620 (VX-970) in Selected Solid Tumors
Nivolumab in Combination With Talazoparib in Melanoma and Mutations in BRCA or BRCA-ness Genes
Nivolumab and Veliparib in Treating Patients With Recurrent or Refractory Stage IV Solid Tumors That…
Cabozantinib and Pamiparib for the Treatment of Advanced of Refractory Solid Tumors
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ